7th Annual Advances in Neurology: Diagnosis and Practical Management of Patients with Nervous System Disorders

Saturday, November 21, 2020, 8:15 AM - 5:00 PM EST, Online


The 7th Annual Advances in Neurology is a full-day virtual CME event that will provide clinicians with an update on diagnostic processes, cutting-edge technologies, and innovative management strategies in these 8 areas of neurology: headache, movement disorders and deep brain stimulation, epilepsy, neurological manifestations of COVID-19, stroke, multiple sclerosis, neuromuscular disease, physician-patient communication. Through didactic lecture, case presentations, and interactive discussions with expert clinicians, attendees will be better enabled to diagnose and manage patients living with neurologic disorders in 2020 and beyond. Patient simulators will interact with faculty to provide an enhanced learning experience for participants.

1. • Discuss existing, new, and potential options for migraine treatment and prevention including oral medications, devices, injectables, and interventional therapies.
2. • Explain the updated guidelines and criteria for diagnosing and categorizing multiple sclerosis and describe a comprehensive management plan.
3. • Identify appropriate treatment approaches for acute ischemic stroke and recognize cases that are appropriate for referral to comprehensive stroke centers offering acute endovascular interventions.
4. • Discuss the neurological manifestations of COVID-19.
5. • Explain the value of electrodiagnostic testing (nerve conduction studies, electromyography, and neuromuscular ultrasound) in securing a neuromuscular disease diagnosis.
6. • Describe surgical options for the treatment of epilepsy and distinguish an ideal candidate.
7. • Identify a movement disorder patient who is a candidate for deep brain stimulation (DBS) surgery.
8. • Explain how autonomic function testing improves recognition and diagnosis of chronic pain syndromes, and more broadly, neurological illnesses.
9. • Outline the elements of a communication plan for delivering bad news to a patient with neurological disease.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (6.75 hours), Non-Physician Attendance (6.75 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Saturday, November 21, 2020